Clari Vest Asset Management LLC Exelixis, Inc. Transaction History

Clari Vest Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$15.15 - $18.89 $562,065 - $700,819	-37,100 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$17.68 - $22.65 $14,144 - $18,120	-800 Reduced 2.11%	37,100 $655,000
Q2 2019 Aug 16, 2019	SELL	$18.93 - $24.75 $7,572 - $9,900	-400 Reduced 1.04%	37,900 $809,000
Q1 2019 May 13, 2019	SELL	$19.6 - $24.76 $3,920 - $4,952	-200 Reduced 0.52%	38,300 $912,000
Q4 2018 Feb 05, 2019	SELL	$13.65 - $21.8 $17,745 - $28,340	-1,300 Reduced 3.27%	38,500 $757,000
Q2 2018 Aug 10, 2018	SELL	$18.56 - $22.45 $128,063 - $154,905	-6,900 Reduced 14.78%	39,800 $856,000
Q1 2018 May 08, 2018	BUY	$22.15 - $31.89 $1.03 Million - $1.49 Million	46,700 New	46,700 $1.03 Million

502

243M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $10.7B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Clari Vest Asset Management LLC with notifications on news.